Amit Hazan
Stock Analyst at Goldman Sachs
(2.09)
# 2,972
Out of 5,008 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $76.82 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $6.65 | -62.41% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.65 | +1,051.52% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $16.08 | -50.25% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $52.15 | +20.81% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $192.53 | +41.28% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $14.66 | +15.96% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $15.01 | +2,798.07% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $34.61 | +27.13% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $76.72 | -4.85% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $22.90 | +131.44% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $30.33 | +87.93% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $13.45 | -29.37% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $133.02 | -21.82% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $11.60 | +417.24% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $98.33 | +16.95% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $369.24 | -59.38% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $95.90 | -52.03% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $440.94 | -45.19% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $99.06 | +78.68% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $188.89 | -22.18% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.57 | +148.41% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $76.82
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $6.65
Upside: -62.41%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.65
Upside: +1,051.52%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $16.08
Upside: -50.25%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $52.15
Upside: +20.81%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $192.53
Upside: +41.28%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $14.66
Upside: +15.96%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $15.01
Upside: +2,798.07%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $34.61
Upside: +27.13%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $76.72
Upside: -4.85%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $22.90
Upside: +131.44%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $30.33
Upside: +87.93%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $13.45
Upside: -29.37%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $133.02
Upside: -21.82%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $11.60
Upside: +417.24%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $98.33
Upside: +16.95%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $369.24
Upside: -59.38%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $95.90
Upside: -52.03%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $440.94
Upside: -45.19%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $99.06
Upside: +78.68%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $188.89
Upside: -22.18%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.57
Upside: +148.41%